Profile #2756

Profile #2756 - Artelis - Belgium

Date: 2009/10/14

Deadline: 2010/10/31

Contact

Organisation	Artelis	Department
Contact person	Diaz Suarez, Ms Tatiana
Email	t.diazsuarez@artelis.be
Address	Rue de Ransbeek 310
Postcode	1120	City	Brussels
Country	Belgium
Telephone	+3222641867	Fax
Website	www.artelis.be

Organisation

Type:	Companies & Enterprises
Is a Small and Medium Sized Enterprise (SME)? YES
Number of Employees	40
Description of research activity:	Artelis’ mission is to create next-generation disposable solutions for cell culture. We have substantial expertise and know-how in process development, in cell culture and in product development. It is worth mentioning that we have developed a complete range of scalable and disposable high-cell-density bioreactors based on our proprietary iCELLis™ technology.

Former participation in an FP European project? NO

Research topics

• HEALTH.2010.4.2.9-1: Optimisation of current methodologies and development ofnovel methods to achieve functional differentiation of human-based target cells in vitro. - CP-IP, min € 4m - max € 5m (max 1 project) - FP7-HEALTH-2010-ALTERNATIVE-TESTING

• HEALTH.2010.4.2.9-2: Exploitation of organ-simulating cellular devices as alternativesfor long-term toxicity testing. - CP-IP, min € 4m - max € 5m (max 1 project) - FP7-HEALTH-2010-ALTERNATIVE-TESTING

• HEALTH.2010.4.2.9-3: Establishment of endpoints and intermediate markers inhuman-based target cells with relevance for repeated dose systemic toxicity testing. - CP-IP, min € 3.5m - max € 4.5m (max 1 project) - FP7-HEALTH-2010-ALTERNATIVE-TESTING

Expertise/commitment offered

Keywords specifying the expertise:	Cell culture, bioreactor, process development, cells, cell therapy, regenerative medicine, cell expansion, disposable, single-use
Description of the expertise:	Artelis’ mission is to create next-generation disposable solutions for cell culture. We have substantial expertise and know-how in process development, in cell culture and in product development. It is worth mentioning that we have developed a complete range of scalable and disposable high-cell-density bioreactors based on our proprietary iCELLis™ technology. Artelis is now focusing on the development of a disposable production system for stem cell expansion. We have several commercial collaborations with cell therapy companies and this provided us with an extensive expertise in stem cell culture. We strongly believe such knowledge is essential to understand and meet the specific needs of organizations involved in regenerative medicine. With a team made up of 8 Device Engineers and 10 highly experienced Scientists, Artelis has integrated all the skills required to ensure stem cell expansion in technologies designed to overcome the specific challenges in the field of stem cell culture.
Commitment offered	Technology

Expectations

Term commitment:

Medium (1 to 3 years)

Expected results for your organisation:

Artelis is  actively seeking partners within the framework of European research programs, particularly in the field of stem cell culture. We strongly believe our skills in terms of cell expansion technologies are essential to understand and meet the specific needs of organizations involved in regenerative medicine. Thanks to our common resources, we can be able to develop new knowledge, new technology and new products.